NCT03247764

Brief Summary

The aim of this study is to register the drug treatment of depression in patients with epilepsy in East China.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Longer than P75 for all trials

Geographic Reach
1 country

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 14, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

January 11, 2022

Status Verified

December 1, 2021

Enrollment Period

3.9 years

First QC Date

August 3, 2017

Last Update Submit

December 19, 2021

Conditions

EpilepsyDepression

Keywords

epilepsydepressiondrug treatment

Outcome Measures

Primary Outcomes (1)

  • the drug treatment rate of depression in patients with epilepsy

    the drug treatment rate at baseline and 6 months at follow-up

    6 months

Secondary Outcomes (1)

  • the influence of depression on seizure-control

    6 months

Study Arms (1)

patients with the comorbidity of epilepsy and depression

the clinical data, psychological assessment, and drug treatments will be investigated in patients with the comorbidity of epilepsy and depression

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with the comorbidity of epilepsy and depression present to the neurology department at 8 tertiary hospitals in East China

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China

Shanghai, Shanghai Municipality, 200040, China

RECRUITING

Department of Neurology, Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310009, China

RECRUITING

Anhui Provincial Hospital

Hefei, China

RECRUITING

Nanjing Brain Hospital

Nanjing, China

RECRUITING

Shanghai General Hospital

Shanghai, China

RECRUITING

The Second Affiliated Hospital of Suzhou University

Suzhou, China

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, China

RECRUITING

MeSH Terms

Conditions

EpilepsyDepression

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehavioral SymptomsBehavior

Study Officials

  • Xin Wang, PhD

    Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Weifeng Peng, MD

CONTACT

862164041990peng.weifeng@zs-hospital.sh.cn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2017

First Posted

August 14, 2017

Study Start

February 1, 2018

Primary Completion

December 31, 2021

Study Completion

January 31, 2022

Last Updated

January 11, 2022

Record last verified: 2021-12

Locations

CN(7)